pediatric asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Airway inflammation due to allergen exposure or infection leads to the release of inflammatory mediators, such as histamines and leukotrienes. This inflammation narrows the airways, causing difficulty in breathing.

• Secondary mechanism: Bronchial hyperresponsiveness results from the inflamed and irritated airways, leading to excessive constriction of the bronchial muscles in response to triggers like exercise, cold air, or pollutants, further obstructing airflow.

• Key complication: Chronic inflammation and repeated asthma attacks can lead to airway remodeling, characterized by structural changes in the airway wall, which may cause persistent asthma symptoms and reduced lung function over time.

Patient Profile

Demographics:

10-year-old male, student

History:

• Key past medical history: Diagnosed with asthma at age 4, history of seasonal allergies

• Current medications: Albuterol inhaler as needed, Montelukast daily

• Allergies: Allergic to penicillin and pollen

Current Presentation:

• Chief complaint: Increased difficulty in breathing, wheezing

• Key symptoms: Persistent cough, shortness of breath, chest tightness, fatigue

• Vital signs: Temperature 99.1°F, heart rate 115 bpm, respiratory rate 28 breaths per minute, oxygen saturation 92% on room air, blood pressure 100/70 mmHg

Section 1

The initial assessment findings reveal that the 10-year-old male patient is experiencing an acute exacerbation of his asthma, likely triggered by recent exposure to pollen, given the season and his known allergies. Upon physical examination, the patient exhibits bilateral wheezing upon auscultation, with diminished breath sounds in the lower lobes, indicating potential airway obstruction. The use of accessory muscles and a prolonged expiratory phase are noted, suggesting increased respiratory effort. The patient's oxygen saturation of 92% indicates mild hypoxemia, requiring prompt intervention to prevent further decline.

Laboratory tests are ordered to rule out concurrent infections and assess the severity of the exacerbation. A complete blood count (CBC) shows an elevated eosinophil count, which is consistent with his history of allergic asthma. A chest X-ray is conducted to exclude other causes of respiratory distress, such as pneumonia, and shows hyperinflation typical of asthma but no signs of infiltrates. Additionally, spirometry is performed, indicating a significant reduction in the forced expiratory volume in one second (FEV1), confirming moderate airway obstruction.

Considering these findings, the healthcare team initiates a tailored treatment plan. The patient is administered a nebulized bronchodilator to provide immediate relief of bronchospasm and is started on a short course of oral corticosteroids to reduce airway inflammation. Education on proper inhaler technique is reinforced with the patient and his guardian to ensure effective use of medication. The team also revisits the patient's asthma action plan, emphasizing the importance of avoiding known triggers, such as pollen, and recognizes the need for a follow-up with a pediatric pulmonologist to evaluate the potential requirement for long-term controller therapy adjustments. This approach aims to stabilize the patient's condition and prevent further complications, setting the stage for evaluating his response to these interventions.

Section 2

As the treatment progresses, the patient initially shows signs of improvement following the administration of the nebulized bronchodilator and oral corticosteroids. His oxygen saturation rises to 95%, and the use of accessory muscles decreases, indicating a reduction in respiratory effort. However, within a few hours, the healthcare team observes a concerning change in the patient’s status. The patient begins to experience increased respiratory rate, now at 32 breaths per minute, and his heart rate has elevated to 120 beats per minute. Although his wheezing is less pronounced, the diminished breath sounds in the lower lobes persist, suggesting that the airway obstruction has not fully resolved.

New diagnostic results reveal a partial response to the current treatment regimen. Follow-up spirometry shows a slight improvement in FEV1, but it remains below the predicted value for his age and height, indicating ongoing moderate airway obstruction. Blood gas analysis is performed, revealing a mild respiratory acidosis with a pH of 7.34 and a PaCO2 of 48 mmHg, suggesting that the patient is beginning to retain CO2, despite the initial intervention efforts. These findings prompt the healthcare team to re-evaluate the current management strategy and consider additional interventions to address the persistent airway obstruction and prevent further deterioration.

Given the evolving clinical picture, the team decides to escalate the treatment plan by initiating a high-flow nasal cannula to deliver humidified oxygen and support ventilation. They also consider introducing a longer-acting bronchodilator and increasing the dosage of corticosteroids. The patient's guardian is involved in discussions regarding the potential for more intensive monitoring in a pediatric intensive care setting if the patient's condition does not stabilize soon. These decisions highlight the importance of continuous assessment and adjustment of the treatment plan, ensuring the patient receives optimal care tailored to his changing needs.

Section 3

As the treatment plan is escalated, the healthcare team closely monitors the patient’s response to the high-flow nasal cannula and the adjusted medication regimen. Within the first hour of the new interventions, there is a noticeable improvement in the patient's respiratory status. His respiratory rate decreases to 28 breaths per minute and his heart rate stabilizes at 110 beats per minute. The supplemental humidified oxygen appears to aid in reducing the work of breathing, as evidenced by decreased use of accessory muscles. Furthermore, the patient's oxygen saturation rises to 97%, suggesting improved oxygenation.

Despite these encouraging signs, the team remains vigilant for potential complications. The patient reports feeling tired and slightly dizzy, prompting a thorough neurological assessment to rule out any hypoxemic or hypercapnic effects on his mental status. Repeat blood gas analysis is performed, showing a pH of 7.36 and a PaCO2 of 45 mmHg, indicating a slight improvement in the respiratory acidosis. However, auscultation reveals persistent diminished breath sounds in the lower lobes, with the presence of coarse crackles, raising concerns about possible atelectasis or early development of a secondary infection due to mucus plugging.

Given these findings, the healthcare team decides to maintain the high-flow nasal cannula and continue with the intensified bronchodilator therapy. Additionally, they initiate chest physiotherapy to promote airway clearance and prevent complications such as pneumonia. The team also educates the patient's guardian about recognizing signs of further respiratory distress and the importance of adhering to the revised treatment plan. This ongoing assessment and adaptation of the management strategy underscore the critical role of responsive and proactive care in managing pediatric asthma with evolving complications.

Section 4

As the healthcare team continues to monitor the patient's progress, they note a slight change in his status. Approximately three hours after the initiation of chest physiotherapy and continued high-flow nasal cannula therapy, the patient begins to exhibit subtle signs of increased respiratory effort. His respiratory rate begins to creep up to 32 breaths per minute, and while his oxygen saturation remains stable at 95%, there is an increase in accessory muscle use, particularly intercostal retractions. This change prompts the team to conduct a thorough reassessment to identify any underlying causes.

During the reassessment, the team performs another auscultation and notes that the coarse crackles in the lower lobes have become more pronounced, and there is a new finding of wheezing in the upper lobes. Concerned about the possibility of mucus plugging or an evolving infection, they decide to obtain a chest X-ray to further evaluate the lung fields. The X-ray reveals areas of patchy infiltrates in the right lower lobe, suggestive of developing atelectasis with a potential early-stage infection. This finding correlates with the patient's persistent cough and increased respiratory secretions.

In response to these new complications, the medical team adjusts the treatment plan. They decide to start a course of antibiotics to address the potential infection, in addition to continuing aggressive airway clearance techniques. They also increase the frequency of nebulized bronchodilator treatments and consider the introduction of mucolytic therapy to help break down the mucus obstructing the airways. This approach aims to reduce the risk of further respiratory compromise and prevent the progression of pneumonia. The patient's guardian is thoroughly briefed on these changes and the importance of close observation for any signs of worsening condition, reinforcing the collaborative effort required in managing complex pediatric asthma cases.

Section 5

Following the adjustment in the treatment plan, the healthcare team closely monitors the patient for any changes in his condition. Over the next 24 hours, there is a notable response to the interventions. The patient's respiratory rate stabilizes at 28 breaths per minute, and the use of accessory muscles begins to decrease, indicating a positive response to the increased frequency of nebulized bronchodilator treatments. The guardian reports that the child's cough has become more productive, with the expectoration of thick, yellow mucus, which suggests the mucolytic therapy is effectively aiding in mucus clearance.

Lab results from a sputum culture taken prior to antibiotic initiation reveal the presence of Streptococcus pneumoniae, confirming the early-stage infection suspected from the chest X-ray. This finding validates the decision to commence antibiotic therapy, and the patient's overall clinical picture begins to improve. Oxygen saturation remains stable at 96% on high-flow nasal cannula, and the coarse crackles auscultated in the lower lobes are less pronounced, while wheezing in the upper lobes is decreasing in intensity.

Despite these improvements, the team remains vigilant, aware that the patient is still at risk for further complications. They continue to emphasize the importance of hydration to the guardian, as adequate fluid intake is crucial for thinning respiratory secretions. The healthcare team plans to reassess the patient in another 24 hours to evaluate the efficacy of the current treatment plan and to ensure that the patient's condition continues to trend positively, thus preventing any progression towards severe respiratory distress or pneumonia. This strategy will facilitate timely adjustments to the treatment regimen, ensuring the best outcomes for the patient.